PD 180970

Discontinued Product

PD 180970 (Cat. No. 4965) has been withdrawn from sale for commercial reasons.
Cat.No. 4965 - PD 180970 | C21H15Cl2FN4O | CAS No. 287204-45-9
Description: p210Bcr/Abl kinase inhibitor; also inhibits c-Src and KIT
Chemical Name: 6-(2,6-Dichlorophenyl)-2-[(4-fluoro-3-methylphenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one
Purity: ≥98% (HPLC)
Citations (1)
Literature (2)

Biological Activity for PD 180970

PD 180970 is an ATP-competitive inhibitor of p210bcr/abl tyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50 values are 80, 80 and 170 nM respectively). Potently inhibits p210bcr/abl autophosphorylation in vitro (IC50 = 5 nM). Also potently inhibits c-Src and KIT (IC50 values are 0.8 and 50 nM, respectively). Induces autophagy and reduces neuroinflammation in animal models of Parkinson's disease.

Licensing Information

Sold for research purposes under agreement from Pfizer Inc.

Technical Data for PD 180970

M. Wt 429.27
Formula C21H15Cl2FN4O
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 287204-45-9
PubChem ID 5311104
Smiles CN(C(C(C4=C(Cl)C=CC=C4Cl)=C3)=O)C1=C3C=NC(NC2=CC(C)=C(F)C=C2)=N1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for PD 180970

References are publications that support the biological activity of the product.

Dorsey et al (2000) The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210bcr-abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res. 60 3127 PMID: 10866298

Corbin et al (2004) Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970. Blood 104 3754 PMID: 15304388

La Rosée et al (2002) Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to ima. mesylate (Gleevec, STI571). Cancer Res. 62 7149 PMID: 12499247

Sn et al (2019) Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration. EBioMedicine 50 260 PMID: 31727601

View Related Products by Product Action

View all Abl Kinase Inhibitors

Keywords: PD 180970, PD 180970 supplier, PD180970, Pfizer, Bcr-Abl, tyrosine, kinase, inhibitors, inhibits, c-Src, KIT, Abl, Kinase, Src, Kinases, Other, RTKs, Autophagy, 4965, Tocris Bioscience

1 Citation for PD 180970

Citations are publications that use Tocris products. Selected citations for PD 180970 include:

Sn et al (2019) Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration. EBioMedicine 50 260 PMID: 31727601

Reviews for PD 180970

There are currently no reviews for this product. Be the first to review PD 180970 and earn rewards!

Have you used PD 180970?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis

Kinases Product Listing

A collection of over 400 products for kinase research, the listing includes inhibitors of:

  • Receptor Tyrosine Kinases
  • Protein Kinases A, C, D and G
  • PI-3 Kinase, Akt and mTOR
  • MAPK Signaling
  • Receptor Serine/Threonine Kinases